References
- Lo YMD, Lo ESF, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996, 88:4390–5.
- Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996; 93:705–48.
- Nelson JL. Matemal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996; 39:191–4.
- Piotrowski P, Croy BA. Maternal cells are widely distributed in murine fetuses in utero. Biol Reprod 1996; 54:1103–10.
- McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion- associated graft-versus- host disease. Transfus Med Rev 1993; 7:37–41.
- Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158:40–7.
- Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC. Smith A, Bean MA, Ober C, Bianchi DW. Microchimerism and HLA-compatible relationships of pregnancy in SSc. Lancet 1998; 351:559–62.
- Welsh K. SSc: chimerism, the blind man, and the scientist. Lancet 1998; 351:540–1.
- Artleft CM, Smith JB, Jimenez, SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338:1186–91.
- Mullinax F. Chimerism and autoimmunity. In Proc Fourth ASEAN Congress. Rheumatol 1993; 39–40.
- Mullinax F, Mullinax GL. Pregnacy-induced SSc, identification of offspring-derived cells in patients with SSc. Arthritis Rheum 1996; 39:S231 (abstract).
- Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS: The lost chord: microchimerism and allograft survival. Immunology Today 1996; 17:577–84.
- Hakim FT, Mackall CL. The immune system: effector and target of graft-versus-host disease. In Graft-vs-Host Disease, ed. 2. Edited by Ferrara JL, Deeg HJ, Burakof St. Marcel Deker, New York 1997; 274–89.
- Mavilla C, Scalefti C, Romagnani P, Carossino AM, Pignone A, Emmi L, Pupilli C, Pizzola G, Maggi E, Romagnani S. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997; 151:1751–8.
- Pandey JP, LeRoy EC. Human cytomegalovirus and the vasuclopathies of autoimmune diseases (especially scleroderma), allograft rejection and coronary restenosis. Arthritis Rheum 1998; 41:10–15.
- Middleton D, Martin J, Doublas J, McClelland M. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994; 58:845–8.
- Miller RG. The veto phenomenon and T-cell regulation. Immunol Today 1986; 7:112–4.
- Nelson JL. Microchimerism and autoimmune disease. N Engl J Med 1998; 338:1224–5.